The World Health Organization reports a steady increase in cancer patients worldwide, marking it as a major health threat. Preventing and treating cancer has become a global priority, with identifying ...

Phase I study of paclitaxel in combination with cyclophosphamide and granulocyte colony-stimulating factor in metastatic breast cancer patients. Clinicians who counsel women about their risk for ...

The analysis of cancer biology data involves extremely heterogeneous data sets, including information from RNA sequencing, genome-wide copy number, DNA methylation data reporting on epigenetic ...

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking ...

The article, by Dr. Patricia Steeg of the National Cancer Institute (NCI) also calls out an “alarming” but debatable decline in survival in other advanced cancers, including ovarian, prostate and ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) just reasserted its position on the map again. The company has announced test results showing tumor shrinkage data from its U.S. Phase II clinical trial in ...

As the sources, types, and amounts of data continue to expand, so will the need for different kinds of analytics to make something of that data. Unfortunately, there is not a one-size-fits-all ...